Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

The FDA approval of lenacapavir as a form of preexposure prophylaxis (PrEP) is a major step for HIV prevention, but its ...

Trent Perry is a 6-foot-4 guard who currently attends Link Academy. The Frisco, TX native is the No. 94 overall prospect in ...

HIV incidence and related deaths in sub-Saharan Africa could significantly increase following the suspension of funding for ...

Florida high school right-hander Aaron Watson, who throws a low-90s sinking fastball, is the Cincinnati Reds' second-round ...

Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...

MSD unveiled the launch of the Phase III trials of MK-8527 at the International AIDS Society (IAS) 2025 conference.

Portland’s new WNBA franchise will finally have a name. On Tuesday, the team is hosting a big launch party at the Moda Center ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...